Archives

  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viabili...

    2025-12-09

    Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability Assay for Proliferation and Cytotoxicity Measurement

    Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes a water-soluble tetrazolium salt (WST-8) for quantifying cell viability and proliferation with high sensitivity and ease of use (APExBIO). The colorimetric output correlates directly with mitochondrial dehydrogenase activity in living cells, enabling reliable cytotoxicity and metabolic assessments (Cui et al., 2025). CCK-8 outperforms MTT, XTT, and similar assays in sensitivity, workflow simplicity, and compatibility with high-throughput formats (TEVProtease). Validated extensively in cancer, neurodegenerative, and drug screening studies, its robust performance is supported by peer-reviewed literature and internal benchmarks. The water solubility of the formazan product eliminates solubilization steps, reducing hands-on time and minimizing assay artifacts.

    Biological Rationale

    Quantitative assessment of cell viability, proliferation, and cytotoxicity is foundational to biomedical research and drug development. Cellular metabolic activity, primarily via mitochondrial dehydrogenases, provides a surrogate marker for live cell number. Colorimetric tetrazolium assays, such as MTT and WST-8-based CCK-8, exploit this link by generating measurable chromogenic products upon reduction by intracellular enzymes (Cui et al., 2025). In cancer research, sensitive detection of cell proliferation informs both mechanistic studies and therapeutic efficacy screens. Similarly, in neurodegenerative disease models, monitoring cell viability is integral for evaluating neuroprotective strategies (AXL1717). CCK-8 supports high-throughput, reproducible quantification across a wide dynamic range, addressing the growing need for precision in cell-based assays (Dibutyryl).

    Mechanism of Action of Cell Counting Kit-8 (CCK-8)

    The Cell Counting Kit-8 (CCK-8) employs WST-8, a water-soluble tetrazolium salt. In viable cells, mitochondrial and cytosolic dehydrogenases reduce WST-8 to produce an orange formazan dye, which remains soluble in the culture medium (LBBroth). The amount of formazan generated is directly proportional to the number of metabolically active cells. The formazan's absorbance is measured at 450 nm using a microplate reader. No solubilization step is required, unlike the MTT assay, simplifying the workflow and reducing operator error. The enzymatic reaction is non-toxic, allowing for subsequent downstream analyses on the same cells.

    Evidence & Benchmarks

    • CCK-8 demonstrates a linear correlation (R2 > 0.99) between absorbance and viable cell number from 500 to 100,000 cells/well under standard 96-well plate culture conditions (Cui et al., 2025).
    • WST-8 formazan is fully water-soluble, enabling direct measurement without organic solvents; this reduces hands-on time by up to 40% compared to MTT (APExBIO).
    • CCK-8 outperforms MTT and XTT in sensitivity, detecting as few as 100 cells/well with low background (TEVProtease).
    • In recent studies, CCK-8 enabled accurate measurement of proliferation and cytotoxicity in gastric cancer cell lines under Helicobacter pylori infection and METTL14 knockdown conditions (Cui et al., 2025).
    • Validated for use in cancer, neurodegenerative, and metabolic disease research, as well as high-throughput drug screening applications (Dibutyryl).

    This article extends the analysis presented in "Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viabili..." by providing direct evidence from recent peer-reviewed studies and exploring practical integration and limitations for translational research.

    For further mechanistic insights and workflow troubleshooting, see "Unlocking Sensitive Cell Analysis with Cell Counting Kit-8...", while this article offers updated benchmarks and clinical translational context.

    Applications, Limits & Misconceptions

    CCK-8 is widely applied in:

    • Cancer research: Quantifying cell proliferation, viability, and drug-induced cytotoxicity.
    • Neurodegenerative disease studies: Assessing protective or toxic effects on neuronal cell populations.
    • Cellular metabolic activity assessment: Monitoring mitochondrial function in metabolic and toxicity assays.
    • High-throughput screening (HTS): Enabling rapid, parallel analysis of large compound libraries.

    The kit is compatible with adherent and suspension cell lines, including primary cells. CCK-8 is particularly suitable for experiments requiring repeated or downstream analyses, as the reagent is minimally cytotoxic (APExBIO).

    Common Pitfalls or Misconceptions

    • Nonviable cell detection: CCK-8 cannot distinguish between different forms of cell death (e.g., apoptosis vs. necrosis); it only measures overall metabolic activity.
    • Interference by compounds: Some reductive agents or colored compounds in the culture medium can artificially alter absorbance values; always include appropriate controls.
    • Plate edge effects: Uneven evaporation at plate edges may skew results; use plate seals and avoid outer wells if possible.
    • Metabolic rate variability: Cell lines with inherently low dehydrogenase activity may yield lower signals, potentially underestimating viability.
    • Non-adherence to incubation times: Deviations from optimized incubation periods (usually 1–4 hours at 37°C) can affect assay linearity and sensitivity.

    Workflow Integration & Parameters

    To use the CCK-8 assay (K1018 kit from APExBIO), seed cells into a 96-well plate at the desired density (typically 1,000–10,000 cells/well) and allow cells to adhere overnight. Add 10 μL of CCK-8 solution per 100 μL culture medium. Incubate for 1–4 hours at 37°C in a humidified CO2 incubator. Measure absorbance at 450 nm using a microplate reader. The water-soluble formazan product allows direct measurement without additional steps. The non-destructive nature of the assay enables further analyses, such as microscopy or flow cytometry, on the same cells. CCK-8 is compatible with automation and HTS platforms (Dibutyryl).

    Conclusion & Outlook

    The Cell Counting Kit-8 (CCK-8) from APExBIO is a robust, sensitive, and convenient cell viability and cytotoxicity assay validated across diverse biomedical research domains. Its WST-8-based chemistry enables direct, high-throughput quantification of viable cells, outperforming legacy methods in sensitivity and workflow efficiency. CCK-8 continues to underpin advances in cancer biology, neurodegeneration, and drug discovery. Ongoing optimization and integration with multiplexed assays will further expand its utility for systems biology and translational research.

    For detailed product information and ordering, visit the Cell Counting Kit-8 (CCK-8) product page.